Pioneer Pharma Holdings Ltd China is 10% at NovaBay Pharmaceuticals, Inc. (NBY). They have made 5 open-market trades across 1 company since 2013, most recently 2014-05-13.
CIK 0001593299
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $6.3M since 2013, never a sale. Across 5 scored buys the stock is up 3.6% at ninety days, and 3.3 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NBY | 426,984 | $833K |
Shares reported on the most recent Form 4, priced at the 2014-05-14 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +12.3% | +3.6% | +3.6% |
| Alpha | +18.1% | +3.3% | +3.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBY | BUY | 2014-05-13 | 2014-05-14 | $0.99 | $64K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2014-05-12 | 2014-05-14 | $0.99 | $115K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2014-05-09 | 2014-05-14 | $0.99 | $316K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2013-12-02 | 2013-12-04 | $1.14 | $5.7M | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2013-11-14 | 2013-12-02 | $1.02 | $110K | +12.3% | +3.6% | +3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.